| Date | Event |
| 23-Nov-09 | RESMED INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits |
| 16-Nov-09 | Price hit new 52-week high ($51.64) |
| 6-Nov-09 | ResMed downgraded by Jefferies & Co |
| 6-Nov-09 | RESMED INC Files SEC form 10-Q, Quarterly Report |
| 5-Nov-09 | Earnings announcement |
| 5-Nov-09 | ResMed Inc. Earnings Call scheduled for 4:30 pm ET today |
| 5-Nov-09 | RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 26-Oct-09 | Price hit new 52-week high ($50.49) |
| 21-Oct-09 | Price hit new 52-week high ($49.79) |
| 1-Oct-09 | RESMED INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation |
| 21-Aug-09 | RESMED INC Files SEC form 10-K, Annual Report |
| 6-Aug-09 | ResMed Inc. Earnings Call scheduled for 4:30 pm ET today |
| 6-Aug-09 | RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 24-Jun-09 | RESMED INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 4-Jun-09 | RESMED INC Files SEC form 8-K, Other Events |
| 8-May-09 | RESMED INC Files SEC form 10-Q, Quarterly Report |
| 7-May-09 | RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 5-Mar-09 | RESMED INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 6-Feb-09 | RESMED INC Files SEC form 10-Q, Quarterly Report |
| 5-Feb-09 | RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits |
| 15-Dec-08 | RESMED INC Files SEC form 8-K, Change in Directors or Principal Officers |
| 26-Nov-08 | RESMED INC Files SEC form 8-K, Change in Directors or Principal Officers |
| 7-Nov-08 | RESMED INC Files SEC form 10-Q, Quarterly Report |
| 6-Nov-08 | RESMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits |